دورية أكاديمية
Long-Term Follow-Up of Single-Fiber Multiple Low-Intensity Energy Laser Ablation Technique of Benign Thyroid Nodules
العنوان: | Long-Term Follow-Up of Single-Fiber Multiple Low-Intensity Energy Laser Ablation Technique of Benign Thyroid Nodules |
---|---|
المؤلفون: | Squarcia, Mattia, Mora, Mireia, Aranda, Gloria, Carrero Cardenal, Enrique J. (Jesús), Martínez, Daniel, Jerez, Ramona, Valero, Ricard, Berenguer, Joan, Halperin, Irene, Hanzu, Felicia A. |
المصدر: | Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques) |
بيانات النشر: | Frontiers Media |
سنة النشر: | 2021 |
المجموعة: | Dipòsit Digital de la Universitat de Barcelona |
مصطلحات موضوعية: | Serveis de cures de llarga durada, Malalties de la tiroide, Ablació amb làser, Long-term care facilities, Thyroid diseases, Laser ablation |
الوصف: | Aim: The short-term and long-term efficacy of different thermal percutaneous ablation techniques remains a topical issue. Our group implemented percutaneous laser ablation (LA), a moving-shot technique to increase efficiency and reduce costs and variability of LA by applying multiple lower-intensity energy illuminations (MLIEI) covering the nodular volume (V) through changes in position of a single laser fiber within the thyroid nodule. The aim of the present study was to evaluate the efficacy of the single-fiber LA-MLIEI during a 5-year follow-up and to identify possible predictors of the final outcome. Methods: Prospective study: Thirty outpatients (23 women and seven men) with benign symptomatic thyroid nodules were assigned to single-fiber LA-MLIEI, between 2012 and 2015. A single LA session was performed under real-time ultrasound (US) guidance using a 1,064-nm continuous-wave laser at 3 W. A 400-µm optical fiber was inserted through a 21-gauge needle, and 3-10 illuminations were performed per nodule, administering between 400 and 850 J/illumination. The total administered energy was calculated on the initial V of the nodule and the estimated ablation area. US evaluation was performed after LA-MLIEI at 1 week and 1, 3, 6, and 12 months and after that annually up to 5 years. Clinical symptoms, laboratory thyroid function during follow-up, and acute and chronic complications of treatment were registered. |
نوع الوثيقة: | article in journal/newspaper |
وصف الملف: | 9 p.; application/pdf |
اللغة: | English |
تدمد: | 2234-943X |
العلاقة: | Reproducció del document publicat a: https://doi.org/10.3389/fonc.2021.584265Test; Frontiers In Oncology, 2021, vol. 11, num. 584265, p. 1-9; https://doi.org/10.3389/fonc.2021.584265Test; http://hdl.handle.net/2445/194794Test; 718114 |
الإتاحة: | https://doi.org/10.3389/fonc.2021.584265Test http://hdl.handle.net/2445/194794Test |
حقوق: | cc-by (c) Squarcia, Mattia et al., 2021 ; https://creativecommons.org/licenses/by/4.0Test/ ; info:eu-repo/semantics/openAccess |
رقم الانضمام: | edsbas.AFC14834 |
قاعدة البيانات: | BASE |
تدمد: | 2234943X |
---|